Literature DB >> 29378770

Management of Membranous Nephropathy in the PLA2R Era.

Andrew S Bomback1.   

Abstract

Entities:  

Keywords:  Antigen-Antibody Complex; Autoantibodies; Autoantigens; Biopsy; Epitopes; Glomerular Basement Membrane; Glomerulonephritis; Group IV Phospholipases A2; Humans; Membranous; PLA2R1 protein; Phospholipase A2; Phospholipases A2; Podocytes; Receptors; Thrombospondins; human; idiopathic nephrotic syndrome; membranous nephropathy

Mesh：

Substances：

Year:  2018        PMID： 29378770      PMCID： PMC5969486          DOI： 10.2215/CJN.12461117

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.

Authors:  C Lefaucheur; B Stengel; D Nochy; P Martel; G S Hill; C Jacquot; J Rossert
Journal:  Kidney Int       Date:  2006-08-30       Impact factor: 10.612

Review 2.  Management of membranous nephropathy: when and what for treatment.

Authors:  Daniel Cattran
Journal:  J Am Soc Nephrol       Date:  2005-03-30       Impact factor: 10.121

3.  Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy.

Authors:  Sjoerd A M E G Timmermans; Rivka Ayalon; Pieter van Paassen; Laurence H Beck; Henk van Rie; Joris J J M Wirtz; Gaico H Verseput; Leon A Frenken; David J Salant; Jan Willem Cohen Tervaert
Journal:  Am J Kidney Dis       Date:  2013-09-08       Impact factor: 8.860

Review 4.  Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Nephron Clin Pract       Date:  2014-11-11

5.  Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.

Authors:  Elion Hoxha; Sigrid Harendza; Hans O Pinnschmidt; Nicola M Tomas; Udo Helmchen; Ulf Panzer; Rolf A K Stahl
Journal:  Nephrol Dial Transplant       Date:  2015-07-03       Impact factor: 5.992

Review 6.  A Proposal for a Serology-Based Approach to Membranous Nephropathy.

Authors:  An S De Vriese; Richard J Glassock; Karl A Nath; Sanjeev Sethi; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 10.121

7.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

Review 8.  Membranous nephropathy: from models to man.

Authors:  Laurence H Beck; David J Salant
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

9.  Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy.

Authors:  Julia M Hofstra; Hanna Debiec; Colin D Short; Timotheé Pellé; Robert Kleta; Peter W Mathieson; Pierre Ronco; Paul E Brenchley; Jack F Wetzels
Journal:  J Am Soc Nephrol       Date:  2012-09-06       Impact factor: 10.121

10.  Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.

Authors:  Anneke P Bech; Julia M Hofstra; Paul E Brenchley; Jack F M Wetzels
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237
  10 in total
  4 in total

Review 1.  Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention.

Authors:  Ruth F Dubin; Eugene P Rhee
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-21       Impact factor: 8.237

Review 2.  Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney.

Authors:  Ping L Zhang; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2021-01-11       Impact factor: 6.513

3.  Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy.

Authors:  Shigeo Hara; Takahiro Tsuji; Yuichiro Fukasawa; Satoshi Hisano; Satoshi Morito; Toshiki Hyodo; Shunsuke Goto; Shinichi Nishi; Akihiro Yoshimoto; Tomoo Itoh
Journal:  Virchows Arch       Date:  2019-03-14       Impact factor: 4.064

4.  The impact of coexisting diabetes mellitus on clinical outcomes in patients with idiopathic membranous nephropathy: a retrospective observational study.

Authors:  Zhiyong Xie; Zhilian Li; Wei Dong; Yuanhan Chen; Ruizhao Li; Yanhua Wu; Huaban Liang; Zhiming Ye; Shuangxin Liu; Wei Shi; Xinling Liang
Journal:  BMC Nephrol       Date:  2020-06-12       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.